Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Sales: 2012-2025

Historic Return on Sales for Adma Biologics (ADMA) over the last 11 years, with Sep 2025 value amounting to 0.43%.

  • Adma Biologics' Return on Sales rose 25.00% to 0.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year increase of 25.00%. This contributed to the annual value of 0.46% for FY2024, which is 57.00% up from last year.
  • Adma Biologics' Return on Sales amounted to 0.43% in Q3 2025, which was down 2.70% from 0.44% recorded in Q2 2025.
  • Adma Biologics' 5-year Return on Sales high stood at 0.46% for Q4 2024, and its period low was -1.58% during Q1 2021.
  • Moreover, its 3-year median value for Return on Sales was 0.09% (2024), whereas its average is 0.13%.
  • Data for Adma Biologics' Return on Sales shows a peak YoY soared of 116bps (in 2021) over the last 5 years.
  • Over the past 5 years, Adma Biologics' Return on Sales (Quarterly) stood at -0.65% in 2021, then spiked by 35bps to -0.30% in 2022, then rose by 21bps to -0.09% in 2023, then spiked by 56bps to 0.46% in 2024, then rose by 25bps to 0.43% in 2025.
  • Its last three reported values are 0.43% in Q3 2025, 0.44% for Q2 2025, and 0.45% during Q1 2025.